Updated Jul 16, 2026 · Last SEC filing 2026-06-03
Cocrystal Pharma, Inc. (COCP) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-03. 4 Form 8-K material event filings were reported by COCP in the last 90 days. InsiderAlpha tracks every COCP SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001412486 |
|---|
| Form 4 filings (90d) | 1 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Latest Form 4 filing | 2026-06-03 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director | P — Open-market purchase | 20.0K | $1.00 | $20K | SEC | |
| FROST PHILLIP MD ET AL | Director | P — Open-market purchase | 50.0K | $0.95 | $47K | SEC | |
| FROST PHILLIP MD ET AL | Director | P — Open-market purchase | 50.0K | $0.95 | $47K | SEC | |
| FROST PHILLIP MD ET AL | Director | P — Open-market purchase | 20.0K | $0.97 | $19K | SEC | |
| FROST PHILLIP MD ET AL | Director | P — Open-market purchase | 40.0K | $0.97 | $39K | SEC | |
| FROST PHILLIP MD ET AL | Director | P — Open-market purchase | 25.0K | $0.97 | $24K | SEC | |
| FROST PHILLIP MD ET AL | Director | P — Open-market purchase | 1.5K | $1.00 | $2K | SEC | |
| FROST PHILLIP MD ET AL | Director | P — Open-market purchase | 2.5K | $0.99 | $2K | SEC | |
| FROST PHILLIP MD ET AL | Director | P — Open-market purchase | 20.0K | $0.94 | $19K | SEC | |
| Hassan Fred | Director | A — Grant or award | 359.7K | $1.39 | $500K | SEC | |
| PFENNIGER RICHARD C JR | Director | A — Grant or award | 20.0K | — | — | SEC | |
| Martin James Joseph | Co-CEO and CFO | A — Grant or award | 3.6K | $1.39 | $5K | SEC | |
| FROST PHILLIP MD ET AL | Director | A — Grant or award | 359.7K | $1.39 | $500K | SEC | |
| Lee Sam | President and Co-CEO | A — Grant or award | 40.0K | — | — | SEC | |
| FROST PHILLIP MD ET AL | Director | A — Grant or award | 27.1K | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Cocrystal Pharma, Inc. (COCP). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| SAPIRSTEIN JAMES | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in COCP insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live COCP dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.